- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
News
Article
Daily Derm Times: May 12, 2025
Author(s):
Key Takeaways
- Multitargeted therapies and AI-driven personalized treatments are revolutionizing atopic dermatitis and hair loss management, improving patient outcomes significantly.
- The ASAP protocol provides an effective non-surgical keloid treatment, achieving high satisfaction and low recurrence rates, particularly for darker skin tones.
Catch up on dermatology news, highlights, and insights from the past 24 hours.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.
Advancing Atopic Dermatitis Treatment by Understanding the Role of Multitargeted Therapies
Explore the evolving landscape of dermatology as experts emphasize the importance of cross-specialty collaboration and patient-centered care in aesthetic medicine.
AI Model Creates Successful Treatment Regimens for Women with Hair Loss
In a new study, AI-driven personalized treatments significantly enhanced hair growth and scalp health, offering innovative solutions for hair loss management.
ASAP Protocol Yields 82% Keloid Resolution
Discover an innovative non-surgical keloid treatment protocol that achieves high satisfaction and low recurrence rates for patients with darker skin tones.
Closing the Gap in Pediatric Atopic Dermatitis: Experts Push for Steroid-Free Advancements
Discover the latest advancements in pediatric atopic dermatitis care, featuring expert insights on innovative treatments and family-centered management strategies.
LEVEL UP Trial Sets New Benchmark for Atopic Dermatitis Treatment
Christopher Bunick, MD, PhD, explains why composite endpoints are now critical for evaluating patient outcomes in AD therapy.
Melanoma Research Foundation and Glowbar Join Forces to Fight Skin Cancer
In honor of Melanoma Awareness Month, Glowbar CEO Rachel Liverman spoke to Dermatology Times about this new collaboration, which aims to increase patients' daily sunscreen use by 2026.
Uncovering Inequities in Hidradenitis Suppurativa Trials
Explore the critical need for diversity in hidradenitis suppurativa clinical trials to address health inequities and improve patient outcomes.
Expanding Global Access to Dermatology: GLODERM and CeraVe Awards Fuel Community-Driven Change
Seven dermatologists have received GLODERM x CeraVe Access Grants to expand skin care access in underserved communities worldwide.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
